KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Gains from Sales and Divestitures: 2009-2011

  • Quest Diagnostics' Gains from Sales and Divestitures rose 25.34% to $930,000 in Q4 2011 from the same period last year, while for Dec 2011 it was $930,000, marking a year-over-year increase of 25.34%. This contributed to the annual value of $930,000 for FY2011, which is 25.34% up from last year.
  • Quest Diagnostics' Gains from Sales and Divestitures amounted to $930,000 in Q4 2011, which was up 25.34% from $742,000 recorded in Q4 2010.
  • In the past 5 years, Quest Diagnostics' Gains from Sales and Divestitures ranged from a high of $930,000 in Q4 2011 and a low of $360,000 during Q4 2009.
  • For the 3-year period, Quest Diagnostics' Gains from Sales and Divestitures averaged around $677,333, with its median value being $742,000 (2010).
  • Data for Quest Diagnostics' Gains from Sales and Divestitures shows a peak YoY skyrocketed of 106.11% (in 2010) over the last 5 years.
  • Quarterly analysis of 3 years shows Quest Diagnostics' Gains from Sales and Divestitures stood at $360,000 in 2009, then soared by 106.11% to $742,000 in 2010, then climbed by 25.34% to $930,000 in 2011.
  • Its Gains from Sales and Divestitures stands at $930,000 for Q4 2011, versus $742,000 for Q4 2010 and $360,000 for Q4 2009.